Versant Ventures Revenue and Competitors

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Versant Ventures's estimated annual revenue is currently $15M per year.(i)
  • Versant Ventures's estimated revenue per employee is $217,391

Employee Data

  • Versant Ventures has 69 Employees.(i)
  • Versant Ventures grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M22-72%N/AN/A
#2
N/A3638%N/AN/A
#3
$7.5M11-21%N/AN/A
#4
$3.5M6350%N/AN/A
#5
N/A11-8%N/AN/A
#6
$7.5M33-6%N/AN/A
#7
$15M5124%N/AN/A
#8
$15M34N/AN/AN/A
#9
$7.5M2624%N/AN/A
#10
$15M24518%N/AN/A
Add Company

Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm's emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm's founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs. For more information, please visit www.versantventures.com.

keywords:N/A

N/A

Total Funding

69

Number of Employees

$15M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Versant Ventures News

2022-04-13 - Cimeio exits stealth with $50M, but its cell therapy technology aims ...

The Versant Ventures-backed company has publicly entered the industry with a $50 million series A financing round. The applied gene editing,...

2022-04-13 - Versant Ventures Launches Cimeio Therapeutics with $50 Million ...

Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great...

2022-04-06 - 858 Therapeutics Expands Board of Directors and Leadership Team

The company debuted in September 2021 with a $60 million Series A financing led by founding investor Versant Ventures, with participation...

2021-04-21 - Versant Ventures : Raises $950 Million Across Three Vehicles

Versant Ventures today announced $950 million in additional capital allocated across a platform of three separate vehicles. These included Versant Venture Capital VIII, a $560 million primary global biotech fund; Versant Voyageurs II, a $140 million booster fund; and Versant Vantage II, a $250 m ...

2021-04-21 - Versant Ventures raises $950M to fund biotech bets

(Kwanchai Lerttanapunyaporn/Getty Images) Biotech investor Versant Ventures has raised $950 million across three funds to fuel a strategy that prioritizes building new companies from scratch. Versant VIII, a $560 million fund, will seed the creation of 20 startups, and the $140 million Voyageur ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9M69-9%N/A
#2
$8.7M69-58%$92.9M
#3
$16.2M69-16%$60.9M
#4
$8.4M69-37%$41.9M
#5
$9M6910%N/A

Versant Ventures Executives


NameTitle
Steve EdelsonVP, IR & Communications
Lara HothVP, Management Company Finance & Accounting
David ReedVP, Fund Finance & Accounting
Dave ReedVice President of Fund Finance